Stem Cells
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online June 14, 2007
Stem Cells Vol. 25 No. 9 September 2007, pp. 2322 -2329
doi:10.1634/stemcells.2006-0839; www.StemCells.com
© 2007 AlphaMed Press

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2006-0839v1
2006-0839v2
25/9/2322    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gobbi, G.
Right arrow Articles by Vitale, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gobbi, G.
Right arrow Articles by Vitale, M.

TISSUE-SPECIFIC STEM CELLS

Timing and Expression Level of Protein Kinase C{varepsilon} Regulate the Megakaryocytic Differentiation of Human CD34 Cells

Giuliana Gobbia, Prisco Mirandolaa, Ivonne Sponzillia, Cristina Michelonia, Chiara Malinvernoa, Lucio Coccob, Marco Vitalea,c

aDepartment of Anatomy, Pharmacology & Forensic Medicine, Human Anatomy Section, University of Parma, Ospedale Maggiore, via Gramsci, Parma, Italy;
bCellular Signalling Laboratory, Department of Anatomical Sciences, University of Bologna, Bologna, Italy;
cIstituto di Genetica Molecolare-Consiglio Nazionale delle Ricerche, Unit of Bologna, c/o Istituti Ortopedici Rizzoli, Bologna, Italy

Key Words. Megakaryocytopoiesis • Stem cells • Cytokines • Thrombopoietin • Tumor necrosis factor-related apoptosis-inducing ligand

Correspondence: Marco Vitale, M.D., Department of Anatomy, Pharmacology & Forensic Medicine, Human Anatomy Section, University of Parma, Ospedale Maggiore, Via Gramsci, 14, I-43100 Parma, Italy. Telephone: +39.0521.033032; Fax: +39.0521.033033; e-mail: marco.vitale{at}unipr.it

Received on December 29, 2006; accepted for publication on June 5, 2007.

First published online in STEM CELLS EXPRESS  June 14, 2007.


Protein kinase C (PKC)-mediated intracellular signaling participates in several key steps of hematopoietic cell differentiation. The {varepsilon} isoform of PKC has been associated with erythroid differentiation as well as with the early phases of megakaryocytic (MK) lineage commitment. Here, we worked on the hypothesis that PKC{varepsilon} expression levels might be modulated during MK differentiation, with a specific role in the early as well as in the late phases of thrombopoiesis. We demonstrate that—at variance with the erythroid lineage development—PKC{varepsilon} is completely downmodulated in TPO-induced CD34 cells from day 6 onward. The forced expression of PKC{varepsilon} in the late phases of MK differentiation delays the phenotypic differentiation of progenitors likely via Bcl-xL upregulation. Moreover, tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), known as a negative regulator of early erythroid expansion, is not apoptogenic for thrombopoietin-induced CD34 cells, but rather accelerates their maturation. However, PKC{varepsilon} levels negatively interfere also with the effects of TRAIL in MK differentiation. PKC{varepsilon} can therefore be considered a signaling intermediate whose expression levels are finely tuned, with a virtually opposite kinetic, in erythroid versus megakaryocytic lineages, to adequately respond to the signaling requirements of the specific hematopoietic lineage.

Disclosure of potential conflicts of interest is found at the end of this article.




This article has been cited by other articles:


Home page
BloodHome page
G. Gobbi, P. Mirandola, C. Carubbi, C. Micheloni, C. Malinverno, P. Lunghi, A. Bonati, and M. Vitale
Phorbol ester-induced PKC{epsilon} down-modulation sensitizes AML cells to TRAIL-induced apoptosis and cell differentiation
Blood, March 26, 2009; 113(13): 3080 - 3087.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
S. G. Olthof, S. Fatrai, A. L. Drayer, M. R. Tyl, E. Vellenga, and J. J. Schuringa
Downregulation of Signal Transducer and Activator of Transcription 5 (STAT5) in CD34+ Cells Promotes Megakaryocytic Development, Whereas Activation of STAT5 Drives Erythropoiesis
Stem Cells, July 1, 2008; 26(7): 1732 - 1742.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS

Copyright © 2007 by AlphaMed Press.